Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025
   Core EBITDA Growth(%) 72.22-

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 72.22 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202672.22
Mar2025-

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 72.22
0
Mar2025 0 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹2,397.7 Cr 0.2% 47.2% 249.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 6.5% 14.8% 48.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 1.2% -2.5% 37.2% Stock Analytics
CIPLA ₹114,393.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -2.2% 1.5% -8.3% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

0.2%

47.2%

249.8%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses